2-(4,4-DIFLUORO-1-PIPERIDINYL)-6-METHOXY-7-(3-(1-PYRROLIDINYL)PROPOXY)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-4-QUINAZOLINAMINE HYDROCHLORIDE
UNII 7X2Z7N7H9W
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(4,4-difluoro-1-piperidinyl)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-n-(tetrahydro-2h-pyran-4-yl)-4-quinazolinamine Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7X2Z7N7H9W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3056862-46-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H37F2N5O3.ClH HQHKQRDAKHRZHD-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(4,4-difluoro-1-piperidinyl)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-n-(tetrahydro-2h-pyran-4-yl)-4-quinazolinamine Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.